Part-Time

Principal Investigator

Updated on 8/23/2026

Rovia Clinical Research

Rovia Clinical Research

51-200 employees

Multispecialty clinical trial site network

No salary listed

Lake City, FL, USA

Remote

MD

Category
Biology & Biotech (1)
Required Skills
FDA Regulations

Get referred to Rovia Clinical Research

See people who can refer or advise you

Requirements
  • MD or DO degree with an active medical license in the relevant state or states.
  • Experience as a Principal Investigator or Sub-Investigator in FDA-regulated clinical trials is preferred.
  • Strong clinical judgment and leadership presence.
Responsibilities
  • Serve as Principal Investigator across clinical trials in major therapeutic indications, including diabetes, hypertension, chronic obstructive pulmonary disease, obesity, depression, pain, Alzheimer’s disease, and infectious diseases.
  • Ensure adherence to Good Clinical Practice and study protocols while collaborating with cross-functional research teams.
  • Provide medical oversight during all trial phases, including patient eligibility review, safety assessments, and data validation.
  • Contribute to internal scientific discussions, quality improvement, and site expansion opportunities.
Desired Qualifications
  • Primary Care Physician or Internist background is strongly preferred.
Rovia Clinical Research

Rovia Clinical Research

View

Rovia Clinical Research runs a network of multi-specialty clinical research sites across the United States to conduct clinical trials for drugs, devices, and diagnostics. It uses a hybrid site model that combines fully-owned, stand-alone centers with embedded specialists in independent medical practices to provide on-site trial support. This setup covers study start-up, patient enrollment, data collection and analysis, logistics, training, and business development, helping sponsors run trials more efficiently. Rovia differentiates itself through its scale, diverse patient access, and integrated services that reduce the burden on investigators, accelerated site activation, and a growing investigator network backed by acquisitions and private equity. The company’s goal is to deliver predictable, high-quality trial execution across multiple therapeutic areas by expanding its network and capabilities, serving major pharmaceutical and biotech clients with timely, well-run studies.

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Jacksonville, Florida

Founded

2007

Get referred to Rovia Clinical Research

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Rovia added StudyMetrix and Coastal Research Institute on September 29, 2025.
  • The new Missouri and North Carolina sites deepen obesity, hepatology, gastroenterology, and pain capabilities.
  • Website claims 100% patient satisfaction, signaling strong participant experience and referral potential.

What critics are saying

  • High turnover and understaffing at Jacksonville erode execution and investigator retention.
  • Marathon refinanced existing debt in November 2025, increasing leverage dependence on lender support.
  • CRO consolidation threatens Rovia if sponsors shift studies to larger networks like Velocity or IQVIA.

What makes Rovia Clinical Research unique

  • Rovia spans 17 sites in 2026, combining owned sites with physician partnerships.
  • Direct EMR access accelerates study start-up and enrollment versus traditional site networks.
  • Gauge Capital backing and Marathon financing support faster acquisitions and expansion.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Performance Bonus

Growth & Insights and Company News

Headcount

6 month growth

16%

1 year growth

26%

2 year growth

26%
Gauge Capital
Sep 29th, 2025
Rovia Clinical Research Announces Acquisitions of StudyMetrix Research and Coastal Research Institute

Gauge Capital, Rovia Clinical Research Announces Acquisitions of StudyMetrix Research and Coastal Research Institute, September 29 2025